Hello, Fool! | Login | Signup | My Fool
Jul 24, 2008 2:22 AM ET | Site Changes | Help
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
View Ticker Page (AZN)
Results 11 - 20 of 50 : 12345
Recs
ElViking (99.74) Submitted: 2/17/07 8:57 PM : Start Price: $54.78 AZN Score: -3.95
Defensive play as global economy transitions from Boom to Slowdown. 3% divvy.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
SESAMEnow (96.92) Submitted: 10/06/07 2:38 PM : Start Price: $50.40 AZN Score: 8.94
Growth is the new name of the game. Drugs are the old name of the game. AZN is both
Report this Post Replies: 1 | Reply | Permalink
KingPortu (52.30) Submitted: 10/29/07 2:34 PM : Start Price: $46.93 AZN Score: -14.89
I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off
catmon (75.16) Submitted: 6/19/08 3:55 PM : Start Price: $41.82 AZN Score: 14.94
Arimidex use will increase sales with favorable ATAC trial released.
manucastle (71.39) Submitted: 7/02/08 10:20 AM : Start Price: $44.51 AZN Score: 3.92
I have purchased AZN today :-http://finance.yahoo.com/q?s=aznEPS = 3.74PE = 11.2 Industry 16.3PB = 4.13 Industry 3.8PS = 2.01 Industry 3.0P/CF = 11.1 Industry 13.3P/FCF = 87.0 Industry 17.4Yield 6.5 Industry 1.5Gross profit margin = 78.7 I...
Rifino (< 20) Submitted: 1/26/07 2:38 PM : Start Price: $51.16 AZN Score: -0.25
The company is a very progressive company and has worked towards improving employee loyalty and satisfaction. It is very customer oriented and this should pay dividends over the long haul.
kumiawan (77.52) Submitted: 10/09/06 12:10 PM : Start Price: $58.09 AZN Score: -15.70
recent $4.5 billion in free cash to buy back stock and pay dividends.
floridabull33 (20.49) Submitted: 3/27/08 2:14 PM : Start Price: $37.33 AZN Score: 27.31
HEALTHCARE.....how can you go wrong with healthcare..astazeneca has it's drugs in a lot of different countries and they are at a low right now this is a good entry point.
gt95ab (49.03) Submitted: 4/02/08 5:01 PM : Start Price: $40.97 AZN Score: 18.22
One man's hell, is another man's jacuzzi...Vytorin ENHANCE study will only help Crestor sales, giving AstraZeneca good growth that will definitely outperform.
timjake (27.40) Submitted: 3/15/08 12:42 PM : Start Price: $35.07 AZN Score: 30.13
Forgein diversivcation. Expanding its uses for core drugs. Restocking its pipeline. Plus near a 52 week low.
Terms & Conditions
RSS Headlines
Fool UK